ROYAL BANK OF CANADA - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 73 filers reported holding AKCEA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 5.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$01
-95.2%
0.00%
Q2 2019$0
-100.0%
21
-65.6%
0.00%
Q1 2019$2,000
-50.0%
61
-44.5%
0.00%
Q3 2018$4,000
+100.0%
110
+71.9%
0.00%
Q2 2018$2,000
+100.0%
64
+8.5%
0.00%
Q1 2018$1,00059
+2850.0%
0.00%
Q4 2017$0
-100.0%
2
-99.9%
0.00%
Q3 2017$39,0001,4070.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Bellevue Group AG 3,162,643$53,575,0000.85%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,723$536,0000.19%
Amia Capital LLP 28,217$478,0000.14%
Motley Fool Asset Management LLC 60,489$1,025,0000.11%
Virtus ETF Advisers LLC 33,059$560,0000.09%
ALTRINSIC GLOBAL ADVISORS LLC 70,286$1,191,0000.05%
A.R.T. Advisors, LLC 53,560$907,0000.04%
TUDOR INVESTMENT CORP ET AL 46,433$787,0000.04%
Caption Management, LLC 54,000$915,0000.03%
Caption Management, LLC 54,000$915,0000.03%
View complete list of AKCEA THERAPEUTICS INC shareholders